Prospective validation of a biomarker-driven response prediction model to romiplostim in lower-risk myelodysplastic neoplasms: results of the EUROPE trial by EMSCO : myelodysplastic neoplasms - Kubasch, Anne Sophie; Giagounidis, Aristoteles; Metzgeroth, Georgia; Jonasova, Anna; Herbst, Regina; Diaz, Jose Miguel Torregrosa; De Renzis, Benoit; Götze, Katharina; Huetter-Kroenke, Marie-Luise; Gourin, Marie-Pierre; Slama, Borhane; Dimicoli-Salazar, Sophie; et al. (Leukemia, 2022)
Gesehen am 14.08.2023